Edit |   |
---|---|
Antigenic Specificity | CD115, Human (Cabiralizumab biosimilar) |
Clone | Cabiralizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG4 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | ELISA, IHC, IF, IP, FCM, Inhib |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD115 Recombinant Antibody (Cabiralizumab). CSF1R inhibitionitors have been developed as a potential route to reduce the presence of TAMs in the tumor microenvironment. As of 2017, CSF1R inhibitionitors that are currently in early stage clinical trials include Pexidartinib, PLX7486, ARRY-382, JNJ-40346527, BLZ945, Emactuzumab, AMG820, IMC-CS4, MCS110, and Cabiralizumab. |
Immunogen | n/a |
Other Names | Anti-CD115 Recombinant Antibody, Research Grade Cabiralizumab, Anti-Human CD115 Recombinant Antibody(Cabiralizumab), FPA-008, Antibody Drug Analogues, Monoclonal Antibody, YR1397, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1613144-80-1 |
Catalog # | YR1397 |
Price | please inquire |
Order / More Info | CD115, Human (Cabiralizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |